China Pharma Holdings, Inc.
corporate_fare Company Profile
China Pharma Holdings, Inc. (NYSE:CPHI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for CPHI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for CPHI spans 10-Q, DEF 14A, PRE 14A.
Recent high-impact activity:
- China Pharma Q3 Loss Widens to $1.9M; Going-Concern Warning Reiterated
- China Pharma Proxy: 1:50 Reverse Split Vote and 8.03M-Share Equity Plan Increase
- China Pharma Seeks Up-to-1:50 Reverse Split and 8.0M-Share Equity Plan Increase
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 89,473 shares in CPHI as of the October 30, 2026 settlement, a 54.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 20.6% of CPHI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.